NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, Wisconsin, the company announced on July 16.

The FDA has approved Bayer’s gadobutrol (Gadavist) injection for use in cardiac MRI, making it the first contrast agent approved for the imaging technique, according to a statement from Bayer.

Bayer announced Monday, July 15, that its Gadavist (gadobutrol) injection has been approved by the FDA for cardiac MR imaging to assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease (CAD).

Preoperative breast MRI (pMRI) can improve the surgical management of patients with newly diagnosed pure ductal carcinoma in situ (DCIS), according to a new study published in Academic Radiology.

CMS revealed details for their newly proposed alternative payment model for radiation oncology on July 10. The American Society of Radiation Oncology (ASTRO) believes the model, with adjustments, "will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure."

MEDNAX, Inc. (NYSE: MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, announced that Chief Medical Officer, Ricardo C. Cury, MD, FSCCT, will present at the 14th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) at the Baltimore Marriott Waterfront in Baltimore, Md. today.

A novel PET radiotracer can help identify changes in the brain’s grey matter that may be indicative of progressive multiple sclerosis (MS), according to a pilot study published in the July issue of Neurology: Neuroimmunology & Neuroinflammation.

Breast cancer screening using digital breast tomosynthesis has risen rapidly in the United States, but that isn’t the case in all regions or across all institutions, according to a new study published in Current Problems in Diagnostic Radiology.